Beta blokery poprawiają rokowanie tylko u chorych po zawale – analiza post hoc badania CHARISMA

Sripal Bangalore i wsp. β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction Post Hoc Analysis From the CHARISMA Trial , LINK: Circulation online

Conclusions—β -blocker use in patients with prior MI but no heart failure was associated with a lower composite cardiovascular outcome driven by lower risk of recurrent MI with no difference in mortality. However, β-blocker use was not associated with lower cardiovascular events in those without MI, with a suggestion of inferior outcome with regard to stroke risk …

Opracowane na podstawie: Circulation / 30 września 2014